Share
𝕏 Facebook LinkedIn

Conductive keratoplasty: a radiofrequency-based technique for the correction of hyperopia.

PAPER pubmed Transactions of the American Ophthalmological Society 2005 Other Effect: benefit Evidence: Moderate

Abstract

PURPOSE: To evaluate the data on the safety, effectiveness, and stability of conductive keratoplasty (CK), a thermal, radiofrequency-based technique for treating 0.75 to 3.00 diopters (D) of spherical hyperopia. METHODS: A prospective, consecutive series, multicenter clinical trial involving 400 hyperopic eyes was conducted by 19 surgeons at 12 centers. The treatment goal was emmetropia. Cohort follow-up was up to 2 years. RESULTS: At 12 months postoperatively, data were available for 97.5% (354/363) of eyes for efficacy variables and 98% (391/400) of eyes for safety variables. A total of 54% of the CK eyes showed 20/20 or better uncorrected visual acuity, and 92% showed 20/40 or better at 12 months. The mean postoperative manifest refractive spherical equivalent was within 0.50 D in 61% and within 1.00 D in 88%. After CK, eyes were approximately 0.50 D myopic at month 1 and effectively emmetropic at 6 months. At 24 months, there was a 20% loss of initial effect. Safety results showed a 2-line loss of best-corrected visual acuity in 2% of the CK-treated eyes. The incidence of induced cylinder of 2.00 D or greater was below 1%. CONCLUSION: The CK technique corrects low to moderate hyperopia effectively and safely and with acceptable stability. It spares the visual axis, does not require the creation of a large flap, and is not associated with postoperative dry eye. CK has value as an alternative to hyperopic LASIK for patients with hyperopia.

AI evidence extraction

At a glance
Study type
Other
Effect direction
benefit
Population
Hyperopic eyes (0.75 to 3.00 diopters spherical hyperopia) undergoing conductive keratoplasty
Sample size
400
Exposure
RF medical device (conductive keratoplasty)
Evidence strength
Moderate
Confidence: 74% · Peer-reviewed: yes

Main findings

In a prospective multicenter clinical trial of 400 hyperopic eyes, 54% achieved 20/20 or better uncorrected visual acuity and 92% achieved 20/40 or better at 12 months. Refractive outcomes were within 0.50 D in 61% and within 1.00 D in 88%; at 24 months there was a reported 20% loss of initial effect. Safety outcomes included a 2-line loss of best-corrected visual acuity in 2% of treated eyes and induced cylinder ≥2.00 D in <1%.

Outcomes measured

  • Uncorrected visual acuity (20/20 or better; 20/40 or better)
  • Manifest refractive spherical equivalent accuracy (within 0.50 D; within 1.00 D)
  • Stability/Regression of refractive effect at 24 months
  • Safety: loss of best-corrected visual acuity (2-line loss)
  • Safety: induced cylinder (≥2.00 D)

Limitations

  • Radiofrequency exposure parameters (e.g., frequency, power, SAR) not reported in abstract
  • No comparator/control group described in abstract
  • Follow-up reported up to 2 years; longer-term stability beyond 24 months not available in abstract
View raw extracted JSON
{
    "study_type": "other",
    "exposure": {
        "band": "RF",
        "source": "medical device (conductive keratoplasty)",
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": null
    },
    "population": "Hyperopic eyes (0.75 to 3.00 diopters spherical hyperopia) undergoing conductive keratoplasty",
    "sample_size": 400,
    "outcomes": [
        "Uncorrected visual acuity (20/20 or better; 20/40 or better)",
        "Manifest refractive spherical equivalent accuracy (within 0.50 D; within 1.00 D)",
        "Stability/Regression of refractive effect at 24 months",
        "Safety: loss of best-corrected visual acuity (2-line loss)",
        "Safety: induced cylinder (≥2.00 D)"
    ],
    "main_findings": "In a prospective multicenter clinical trial of 400 hyperopic eyes, 54% achieved 20/20 or better uncorrected visual acuity and 92% achieved 20/40 or better at 12 months. Refractive outcomes were within 0.50 D in 61% and within 1.00 D in 88%; at 24 months there was a reported 20% loss of initial effect. Safety outcomes included a 2-line loss of best-corrected visual acuity in 2% of treated eyes and induced cylinder ≥2.00 D in <1%.",
    "effect_direction": "benefit",
    "limitations": [
        "Radiofrequency exposure parameters (e.g., frequency, power, SAR) not reported in abstract",
        "No comparator/control group described in abstract",
        "Follow-up reported up to 2 years; longer-term stability beyond 24 months not available in abstract"
    ],
    "evidence_strength": "moderate",
    "confidence": 0.7399999999999999911182158029987476766109466552734375,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "conductive keratoplasty",
        "radiofrequency",
        "thermal technique",
        "hyperopia",
        "clinical trial",
        "multicenter",
        "safety",
        "effectiveness",
        "stability"
    ],
    "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.